Lung spirometry parameters and diffusion capacity are decreased in patients with Type 2 diabetes

Diabetic Medicine

Volumn 29, Issue 2, 2012, Pages 212-219

  Klein, O L ^a   Kalhan, R ^a   Williams, M V ^a   Tipping, M ^a   Lee, J ^a   Peng, J ^a   Smith, L J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Carbon monoxide diffusing capacity; Ethnicity; Forced expiratory volume; Forced vital capacity; Heart failure

Indexed keywords

CARBON MONOXIDE; INSULIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY HEIGHT; BODY MASS; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART FAILURE; HISPANIC; HUMAN; INSULIN TREATMENT; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RACE DIFFERENCE; SMOKING; SPIROMETRY;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEART FAILURE; HISPANIC AMERICANS; HUMANS; MALE; MAXIMAL EXPIRATORY FLOW RATE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; SMOKING; SPIROMETRY; VITAL CAPACITY; YOUNG ADULT;

EID: 84862907665     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03394.x     Document Type: Article

References (30)

1. Brownlee M, Vlassara H, Cerami A. Non-enzymatic glycosylation and the pathogenesis of diabetic complications. Ann Int Med 1984; 101: 527-537.
2. Hsia CC, Raskin P. Lung involvement in diabetes. Does it matter? Diabetes Care 2008; 31: 828-829.
3. Ofulue AF, Thurlbeck WM. Experimental diabetes and the lung. In vivo connective tissue metabolism. Am Rev Respir Dis 1988; 138: 284-289.
4. Popov D, Simionescu M. Alterations of lung structure in experimental diabetes and diabetes associated with hyperlipidemia in hamsters. Eur Respir J 1997; 10: 1850-1858.
5. Farina J, Furio V, Fernandez-Acenero MJ, Muzas MA. Nodular fibrosis of the lung in diabetes mellitus. Virchows Arch 1995; 427: 61-63.
6. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelium and capillaries: quantitative changes with aging and in diabetes mellitus. Am Rev Respir Ds. 1979; 120: 973-983.
7. Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 1999; 66: 14-19.
8. Watanabe K, Senju S, Toyoshima H, Yoshida M. Thickness of the basement membrane of bronchial epithelial cells in lung diseases as determined by transbronchial biopsy. Respir Med 1997; 91: 406-410.
9. Walter RE, Beiser A, Givelber RJ, O'Connor GT, Gottlieb DJ. Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 2003; 167: 911-916.
10. Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Cox CE et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008; 31: 741-746.
11. Davis TME, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes, the Fremantle Diabetes Study. Diabetes Res Clin Pract 2000; 50: 153-159.
12. Lange P, Parner J, Schnohr P, Jensen G. Copenhagen City Heart Study, longitudinal analysis of ventilator capacity in diabetic and non-diabetic adults. Eur Respir J 2002; 20: 1406-1412.
13. Litonjua AA, Lazarus R, Sparrow D, Demolles D, Weiss ST. Lung function in type 2 diabetes: the Normative Aging Study. Respir Med 2005; 99: 1583-1590.
14. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004; 47: 195-203.
15. Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med 2010; 27: 977-987.
16. Chance WW, Rhee C, Yilmaz C, Dane DM, Pruneda ML, Raskin P et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 2008; 31: 1596-1601.
17. Piccini JP, Klein L, Gheorghiade M, Bonow RO. New insights into diastolic heart failure: role of diabetes mellitus. Am J Med 2004; 116: 64S-75S.
18. Hankinson JL, Bang KM. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population. Am Rev Respir Dis 1991; 143: 516-521.
19. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187.
20. Guazzi M, Brambilla R, De Vita S, Guazzi MD. Diabetes worsens pulmonary diffusion in heart failure, and insulin counteracts this effect. Am J Respir Crit Care Med 2002; 166: 978-982.
21. Roger VL, Go AS, Lloyd-Jones DM et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.
22. Lanting LC, Joung IM, Mackenbach, Lamberts SW, Bootsma AH. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients. Diabetes Care 2005; 28: 2280-2288.
23. Kerter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson M, Selby JV. Ethnic disparities in diabetic complications in an insured population. J Am Med Assoc 2002; 287: 2517-2519.
24. Ehrlich SF, Quesenberry CP Jr, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010; 33: 55-60.
25. Gudmundsson G, Gislason T, Lindberg E et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006; 7: 109-116.
26. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sorensen HT. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008; 31: 1541-1545.
27. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005; 128: 3233-3239.
28. Klein OL, Smith LJ, Tipping M, Peng J, Williams MV Reduced diffusion lung capacity in patients with type 2 diabetes mellitus predicts hospitalization for pneumonia. Diab Res Clin Pract 2011; 92: e12-e15.
29. Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med 2005; 118: 205-211.
30. Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC et al. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. Lancet 2010; 375: 2244-2253.